Foghorn Therapeutics Inc. (FHTX) SEC Filings — 2025
18 SEC filings for Foghorn Therapeutics Inc. (FHTX) in 2025.
Filings
- Foghorn Therapeutics Announces Board and Executive Changes — 8-K · Dec 4, 2025
- Foghorn Therapeutics Files 8-K — 8-K · Nov 7, 2025
- Foghorn Narrows Losses, R&D Spend Drops 19% Amid Cash Burn — 10-Q · Nov 5, 2025
- Foghorn Therapeutics Files 8-K — 8-K · Oct 30, 2025
- Foghorn Therapeutics Inc. 8-K Filing — 8-K · Sep 2, 2025
- Foghorn Narrows Losses, Boosts Revenue on Collaboration Gains — 10-Q · Aug 5, 2025
- Foghorn Therapeutics Inc. 8-K Filing — 8-K · Jul 1, 2025
- Foghorn Therapeutics Files 8-K for Security Holder Vote — 8-K · Jun 17, 2025
- Foghorn Therapeutics Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Foghorn Therapeutics Files 2025 Proxy Statement — DEF 14A · May 5, 2025
- Foghorn Therapeutics: Director Departure, New Officer, Comp Changes — 8-K · May 1, 2025
- Foghorn Therapeutics Files 8-K — 8-K · Apr 28, 2025
- Foghorn Therapeutics Files 8-K — 8-K · Mar 24, 2025
- Foghorn Therapeutics Files 8-K — 8-K · Mar 20, 2025
- Foghorn Therapeutics Files 2024 10-K — 10-K · Mar 6, 2025
- Foghorn Therapeutics Files 8-K — 8-K · Feb 3, 2025
- Foghorn Therapeutics Faces Nasdaq Listing Rule Violation — 8-K · Jan 24, 2025
- Foghorn Therapeutics Files 8-K — 8-K · Jan 13, 2025